Eledon Pharmaceuticals (ELDN) vs Oramed Pharmaceuticals (ORMP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Oramed Pharmaceuticals (ORMP) has outperformed Eledon Pharmaceuticals (ELDN) over the past year, gaining 75.7% versus a loss of 15.7%. Over five years, ELDN leads with a -57.0% price change compared with -81.0% for ORMP. Eledon Pharmaceuticals is the larger company by market cap ($196.7 million vs $174.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELDN | ORMP |
|---|---|---|
| Share price | $2.42 | $4.20 |
| Market cap | $196.65M | $174.71M |
| 1-day change | 0.00% | -3.89% |
| YTD return | +60.26% | +47.37% |
| 1-year return | -15.68% | +75.73% |
| 5-year return | -57.02% | -80.96% |
| P/E ratio (TTM) | — | 1.02 |
| EPS (TTM) | $-0.90 | $4.13 |
| Dividend yield | 0.00% | 5.92% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.60 | $5.47 |
| 52-week low | $1.35 | $2.09 |
| Distance from 52-week high | -47.39% | -23.22% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +271.90% | +66.67% |
| Average volume | 935.08K | 190.50K |
| Shares outstanding | 81.26M | 41.60M |
| Employees | 33 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ORMP has outperformed ELDN by 91.4 percentage points over the past year.
- Oramed Pharmaceuticals offers a meaningfully higher dividend yield (5.92% vs 0.00%).
About Eledon Pharmaceuticals
ELDN stock →Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees
About Oramed Pharmaceuticals
ORMP stock →Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
Health Care · Biotechnology: Pharmaceutical Preparations
ELDN vs ORMP FAQ
Which is bigger, Eledon Pharmaceuticals or Oramed Pharmaceuticals?
Eledon Pharmaceuticals (ELDN) is larger, with a market capitalization of $196.65M compared with $174.71M for Oramed Pharmaceuticals (ORMP).
Which stock has performed better over the past year, ELDN or ORMP?
ORMP returned +75.73% over the past 12 months, compared with -15.68% for ELDN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Eledon Pharmaceuticals or Oramed Pharmaceuticals?
Oramed Pharmaceuticals pays a dividend yielding 5.92%, while Eledon Pharmaceuticals does not currently pay a regular dividend.
Are Eledon Pharmaceuticals and Oramed Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.